Paper42012504
SLC25A21 promotes ferroptosis by inducing mitochondrial GPX4 deficiency in colorectal cancer.
Liu W and 10 others. Cell Mol Life Sci, 2026. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. SLC25A21 promotes ferroptosis by inducing mitochondrial GPX4 deficiency in colorectal cancer. Papers, record 42012504. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42012504
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- SLC25A21 promotes ferroptosis by inducing mitochondrial GPX4 deficiency in colorectal cancer.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Ferroptosis | Major topic |
| Colorectal Neoplasms | Major topic |
| Phospholipid Hydroperoxide Glutathione Peroxidase | Major topic |
| Mitochondria | Major topic |
| Dicarboxylic Acid Transporters | Major topic |
| Mitochondrial Membrane Transport Proteins | Major topic |
| Mitochondrial Proteins | Major topic |
| Humans | |
| Animals | |
| Reactive Oxygen Species | |
| Cell Line, Tumor | |
| Mice | |
| Lipid Peroxidation | |
| Mice, Nude | |
| Apoptosis |
Source PubMed
Grants5
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 31970703 | Innovative Research Group Project of the National Natural Science Foundation of China | PubMed | ||
| 32570891 | Innovative Research Group Project of the National Natural Science Foundation of China | PubMed | ||
| 2025A1515010593 | Natural Science Foundation of Guangdong Province | PubMed | ||
| 2022A1515012472 | Natural Science Foundation of Guangdong Province | PubMed | ||
| 2021A1515010544 | Natural Science Foundation of Guangdong Province | PubMed |
Source PubMed
References39
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32165281 | Lipid peroxidation and ferroptosis: The role of GSH and GPx4. | Free Radic Biol Med | 2020 | https://conductscience.org/library/papers/32165281 | PubMed |
| 2 | 11083877 | Identification of the human mitochondrial oxodicarboxylate carrier. Bacterial expression, reconstitution, functional characterization, tissue distribution, and chromosomal location. | J Biol Chem | 2001 | https://conductscience.org/library/papers/11083877 | PubMed |
| 3 | 33538338 | Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. | CA Cancer J Clin | 2021 | https://conductscience.org/library/papers/33538338 | PubMed |
| 4 | 37188001 | Forkhead box O3 attenuates osteoarthritis by suppressing ferroptosis through inactivation of NF-κB/MAPK signaling. | J Orthop Translat | 2023 | https://conductscience.org/library/papers/37188001 | PubMed |
| 5 | 37794028 | Autophagy: Regulator of cell death. | Cell Death Dis | 2023 | https://conductscience.org/library/papers/37794028 | PubMed |
| 6 | 17360195 | Expression, purification, characterization of human 3-methylcrotonyl-CoA carboxylase (MCCC). | Protein Expr Purif | 2007 | https://conductscience.org/library/papers/17360195 | PubMed |
| 7 | 31347092 | The Evolving Biomarker Landscape for Treatment Selection in Metastatic Colorectal Cancer. | Drugs | 2019 | https://conductscience.org/library/papers/31347092 | PubMed |
| 8 | 38488564 | p38 MAPK inhibitor SB202190 suppresses ferroptosis in the glutamate-induced retinal excitotoxicity glaucoma model. | Neural Regen Res | 2024 | https://conductscience.org/library/papers/38488564 | PubMed |
| 9 | 40783384 | Defective lipid droplet biogenesis exacerbates oleic acid-induced cellular homeostasis disruption and ferroptosis in mouse cardiac endothelial cells. | Cell Death Discov | 2025 | https://conductscience.org/library/papers/40783384 | PubMed |
| 10 | 40895322 | A Simpler, More Convenient and More Comfortable Approach for Treating Multiple Keratinocytic Carcinoma. | Phenomics | 2025 | https://conductscience.org/library/papers/40895322 | PubMed |
| 11 | 37324946 | The crosstalk between ferroptosis and mitochondrial dynamic regulatory networks. | Int J Biol Sci | 2023 | https://conductscience.org/library/papers/37324946 | PubMed |
| 12 | 35220675 | Tumour cells are sensitised to ferroptosis via RB1CC1-mediated transcriptional reprogramming. | Clin Transl Med | 2022 | https://conductscience.org/library/papers/35220675 | PubMed |
| 13 | 38779359 | Depletion of squalene epoxidase in synergy with glutathione peroxidase 4 inhibitor RSL3 overcomes oxidative stress resistance in lung squamous cell carcinoma. | Precis Clin Med | 2024 | https://conductscience.org/library/papers/38779359 | PubMed |
| 14 | 34095147 | A Prognostic Ferroptosis-Related lncRNAs Signature Associated With Immune Landscape and Radiotherapy Response in Glioma. | Front Cell Dev Biol | 2021 | https://conductscience.org/library/papers/34095147 | PubMed |
| 15 | 37272058 | GPX4 in cell death, autophagy, and disease. | Autophagy | 2023 | https://conductscience.org/library/papers/37272058 | PubMed |
| 16 | 37580745 | The emerging roles of MAPK-AMPK in ferroptosis regulatory network. | Cell Commun Signal | 2023 | https://conductscience.org/library/papers/37580745 | PubMed |
| 17 | 35760796 | Cancer cells dying from ferroptosis impede dendritic cell-mediated anti-tumor immunity. | Nat Commun | 2022 | https://conductscience.org/library/papers/35760796 | PubMed |
| 18 | 25402683 | Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice. | Nat Cell Biol | 2014 | https://conductscience.org/library/papers/25402683 | PubMed |
| 19 | 36828120 | FUNDC1 interacts with GPx4 to govern hepatic ferroptosis and fibrotic injury through a mitophagy-dependent manner. | J Adv Res | 2024 | https://conductscience.org/library/papers/36828120 | PubMed |
| 20 | 36032135 | Prediction of prognosis, immunogenicity and efficacy of immunotherapy based on glutamine metabolism in lung adenocarcinoma. | Front Immunol | 2022 | https://conductscience.org/library/papers/36032135 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42422878 | RBMS3 promotes ferroptosis in colorectal cancer and is suppressed by M2 tumor-associated macrophages via STAT3 activation. | Front Mol Biosci | 2026 | https://conductscience.org/library/papers/42422878 |
Source PubMed
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| GPX4 | 2879 | PubTator's text mining | https://conductscience.org/library/genes/2879 | NCBI Gene |
| SLC25A21 | 89874 | PubTator's text mining | https://conductscience.org/library/genes/89874 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42012504
GET https://conductscience.org/api/papers/v1/42012504/references?page=2